Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PRECIGEN, INC. | 503,183 | reported | 14 Mar 2024 | tx 53+1,373,288−332,589 |
| Theravance Biopharma, Inc. | 91,204 | reported | 19 May 2025 | tx 21+237,082 |
| BRISTOL MYERS SQUIBB CO | 60,000 | reported | 10 Sept 2003 | tx 1+10,000 |
| Praxis Precision Medicines, Inc. | 17,251 | reported | 24 Sept 2025 | tx 13+180,414−12,251 |
| MGI PHARMA INC | 0 | reported | 28 Jan 2008 | tx 24+30,000−118,074 |
| Talecris Biotherapeutics Holdings Corp. | 0 | reported | 01 Jun 2011 | tx 6+18,642−18,642 |
| Kinnate Biopharma Inc. | 0 | reported | 03 Apr 2024 | tx 7+65,500−187,003 |
| ALPHARMA INC | 0 | reported | 29 Dec 2008 | tx 57+530,720−510,315.68 |
| ISTA PHARMACEUTICALS INC | 0 | reported | 06 Jun 2012 | tx 17+103,132−151,632 |
| IMMUNOGEN INC | 0 | reported | 12 Feb 2024 | tx 69+507,313−497,354 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 24 Sept 2025 | EXERCISE | Praxis Precision Medicines, Inc. | 1,753 | 44.04 USD | |
| 24 Sept 2025 | EXERCISE | Praxis Precision Medicines, Inc. | 8,566 | 44.25 USD | |
| 24 Sept 2025 | EXERCISE | Praxis Precision Medicines, Inc. | 1,932 | 14.36 USD | |
| 24 Sept 2025 | EXERCISE | Praxis Precision Medicines, Inc. | 1,932 | 0.00 USD | deriv |
| 24 Sept 2025 | EXERCISE | Praxis Precision Medicines, Inc. | 1,753 | 0.00 USD | deriv |
| 24 Sept 2025 | EXERCISE | Praxis Precision Medicines, Inc. | 8,566 | 0.00 USD | deriv |
| 26 Jun 2025 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 10,520 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Theravance Biopharma, Inc. | 10,649 | 0.00 USD | |
| 19 May 2025 | GRANT_AWARD | Theravance Biopharma, Inc. | 24,258 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Praxis Precision Medicines, Inc. | 8,566 | 0.00 USD | deriv |
| 08 May 2024 | GRANT_AWARD | Theravance Biopharma, Inc. | 10,537 | 0.00 USD | |
| 08 May 2024 | GRANT_AWARD | Theravance Biopharma, Inc. | 23,576 | 0.00 USD | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 25,000 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 20,250 | — | deriv |
| 03 Apr 2024 | OTHER | Kinnate Biopharma Inc. | 121,503 | — | deriv |
| 14 Mar 2024 | GRANT_AWARD | PRECIGEN, INC. | 39,510 | 1.43 USD | |
| 14 Mar 2024 | GRANT_AWARD | PRECIGEN, INC. | 101,626 | 0.00 USD | deriv |
| 14 Mar 2024 | GRANT_AWARD | PRECIGEN, INC. | 87,412 | 0.00 USD | deriv |
| 09 Mar 2024 | EXERCISE | PRECIGEN, INC. | 106,837 | — | |
| 09 Mar 2024 | EXERCISE | PRECIGEN, INC. | 106,837 | 0.00 USD | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 103,000 | — | |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 13,090 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 142,667 | — | deriv |
| 12 Feb 2024 | OTHER | IMMUNOGEN INC | 10,000 | — | deriv |
3 purchases reported after at least 12 months of silence — most recent on 08 Jun 2022.